Skip to main content
. 2018 Jun 28;4(9). doi: 10.1001/jamaoncol.2018.1812

Figure 2. Kaplan-Meier Plot of Progression-Free Survival (PFS) Among Patients Treated With the Maximum Tolerated Dosage of Tucatinib Combined With Ado-Trastuzumab Emtansine.

Figure 2.

Abbreviations: BM, brain metastases; Mets, metastases; NBM, no brain metastases; NE, nonevaluable.